
    
      Currently Left Ventricular Assist Device-only patients are being implanted and followed.
      Feasibility of autologous mesenchymal stem cell grafting in patients receiving heart mate
      will be assessed in a 4 patient pilot trial. Mesenchymal stem cell are delivered during Left
      Ventricular Assist Device surgery by intramyocardial infusions. Recovery of contractile
      function of the heart is assessed during attempts to wean patients from Left Ventricular
      Assist Device
    
  